Multi-Omics Exploration of the Mechanism of Curcumol to Reduce Invasion and Metastasis of Nasopharyngeal Carcinoma by Inhibiting NCL/EBNA1-Mediated UBE2C Upregulation
Open Access
- 9 September 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (9) , 1142
Abstract
Nasopharyngeal carcinoma (NPC) is closely linked to Epstein–Barr virus (EBV) infection. Curcumae Rhizoma, a traditional Chinese herb, has shown antitumor effects, primarily through its component curcumol (Cur), which has been shown to reduce NPC cell invasion and migration by targeting nucleolin (NCL) and Epstein–Barr Virus Nuclear Antigen 1 (EBNA1). We constructed an EBV-positive NPC cell model using C666-1 cells and performed transcriptomics studies after treatment with curcumol, which revealed a significant enrichment of ubiquitin-mediated proteolysis, the PI3K-AKT and mTOR signaling pathways, cell cycle and apoptosis involved in tumor invasion and migration. To investigate the importance of NCL and EBNA1 in curcumol-resistant EBV-positive NPC, we performed a multi-omics study using short hairpin NCL (shNCL) and shEBNA1 EBV-positive NPC cells, and the proteomics results showed enrichment in complement and coagulation cascades and ubiquitin-mediated proteolysis signaling pathways. Here, we focused on ubiquitin-conjugating enzyme E2C (UBE2C), which plays an important role in the ubiquitin-mediated proteolysis signaling pathway. In addition, metabolomics revealed that UBE2C is highly associated with 4-Aminobutanoic acid (GABA). In vitro studies further validated the function of the key targets, suggesting that UBE2C plays an important role in NCL and EBNA1-mediated curcumol resistance to nasopharyngeal carcinoma invasion and metastasis.Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2023GXNSFBA026199, GuikeAA23023035-7, 82160768, 82002822)
- Project Guangxi Special Fund Project for Innovation-Driven Development (2023GXNSFBA026199, GuikeAA23023035-7, 82160768, 82002822)
- National Natural Science Foundation of China (2023GXNSFBA026199, GuikeAA23023035-7, 82160768, 82002822)
This publication has 36 references indexed in Scilit:
- Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathwayJournal of Ethnopharmacology, 2023
- Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion ratsJournal of Ethnopharmacology, 2022
- Modification of lysine deacetylation regulates curcumol‐induced necroptosis through autophagy in hepatic stellate cellsPhytotherapy Research, 2022
- Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancerBreast Cancer Research and Treatment, 2022
- The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaCancer Communications, 2021
- Curcumol inhibits EBV-positive Nasopharyngeal carcinoma migration and invasion by targeting nucleolinBiochemical Pharmacology, 2021
- Chemotherapy and chemo-resistance in nasopharyngeal carcinomaEuropean Journal of Medicinal Chemistry, 2020
- Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cellsJournal of Proteomics, 2018
- Ubiquitin-conjugating enzyme E2C: A potential cancer biomarkerThe International Journal of Biochemistry & Cell Biology, 2014
- Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal CarcinomaThe American Journal of Pathology, 2011